FNY Investment Advisers’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

FNY Investment Advisers’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-167	Closed	-$8K	–	961
2022 Q1	$8K	Sell	167 -266	-61%	-$13.1K	0.01%	492
2021 Q4	$30K	Sell	433 -390	-47%	-$32.9K	0.02%	294
2021 Q3	$76K	Sell	823 -1,266	-61%	-$120K	0.04%	270
2021 Q2	$209K	Buy	2,089 +1,089	+109%	+$106K	0.08%	187
2021 Q1	$93K	Buy	1,000 +373	+59%	+$37.8K	0.03%	325
2020 Q4	$51K	Sell	627 -6	-0.9%	-$512	0.01%	383
2020 Q3	$54K	Buy	633 +166	+36%	+$19.3K	0.02%	244
2020 Q2	$43K	Buy	+467	New	+$25.7K	0.03%	214
2018 Q4	–	Sell	-167	Closed	-$12K	–	1097
2018 Q3	$12K	Hold	167	–	–	﹤0.01%	510
2018 Q2	$13K	Buy	+167	New	+$16.1K	0.01%	409

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

FNY Investment Advisers's VBIV Position: Q2 2022 in Review

FNY Investment Advisers sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2022, closing a stake of 167 shares — an estimated $8K sold.

FNY Investment Advisers first reported a position in VBIV in Q2 2018 and held it in 10 quarters. The position peaked at $209K in Q2 2021. 130 funds tracked by Wall St. Rank hold VBIV as of Q2 2022.

FNY Investment Advisers reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2022 after selling out during the quarter.
FNY Investment Advisers sold 167 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2022, an estimated $8K.
FNY Investment Advisers first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 10 quarters.
FNY Investment Advisers's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $209K in Q2 2021.
130 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2022.

Based on FNY Investment Advisers's 13F filing for Q2 2022, filed 12 Jul 2022.